Paper29907809
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
Shimoni A and 13 others. Leukemia, 2019. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide. Papers, record 29907809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29907809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Graft vs Host Disease | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Killer Cells, Natural | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Receptors, KIR | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Histocompatibility | |
| Humans | |
| Immunosuppressive Agents | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Retrospective Studies | |
| Survival Rate | |
| Transplantation Conditioning | |
| Transplantation, Haploidentical | |
| Young Adult |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19961944 | Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19961944 | PubMed |
| 2 | 28986344 | NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications. | Blood | 2018 | https://conductscience.org/library/papers/28986344 | PubMed |
| 3 | 24319201 | Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL. | Hematology Am Soc Hematol Educ Program | 2013 | https://conductscience.org/library/papers/24319201 | PubMed |
| 4 | 19167686 | Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. | Biol Blood Marrow Transplant | 2009 | https://conductscience.org/library/papers/19167686 | PubMed |
| 5 | 11896281 | Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. | Science | 2002 | https://conductscience.org/library/papers/11896281 | PubMed |
| 6 | 22892554 | Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies. | Biol Blood Marrow Transplant | 2013 | https://conductscience.org/library/papers/22892554 | PubMed |
| 7 | 28558762 | Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. | J Hematol Oncol | 2017 | https://conductscience.org/library/papers/28558762 | PubMed |
| 8 | 25949893 | Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent. | Oncoimmunology | 2015 | https://conductscience.org/library/papers/25949893 | PubMed |
| 9 | 26130705 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. | Blood | 2015 | https://conductscience.org/library/papers/26130705 | PubMed |
| 10 | 27071449 | How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? | J Hematol Oncol | 2016 | https://conductscience.org/library/papers/27071449 | PubMed |
| 11 | 21045194 | NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. | Blood | 2011 | https://conductscience.org/library/papers/21045194 | PubMed |
| 12 | 26305035 | Modern approaches to HLA-haploidentical blood or marrow transplantation. | Nat Rev Clin Oncol | 2016 | https://conductscience.org/library/papers/26305035 | PubMed |
| 13 | 27788762 | Selecting the best haploidentical donor. | Semin Hematol | 2016 | https://conductscience.org/library/papers/27788762 | PubMed |
| 14 | 19925877 | Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19925877 | PubMed |
| 15 | 16131567 | KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. | Blood | 2005 | https://conductscience.org/library/papers/16131567 | PubMed |
| 16 | 25263628 | Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors. | Biol Blood Marrow Transplant | 2014 | https://conductscience.org/library/papers/25263628 | PubMed |
| 17 | 21703971 | Conflicting impact of alloreactive NK cells on transplantation outcomes after haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences? | Biol Blood Marrow Transplant | 2011 | https://conductscience.org/library/papers/21703971 | PubMed |
| 18 | 17371948 | Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. | Blood | 2007 | https://conductscience.org/library/papers/17371948 | PubMed |
| 19 | 10204198 | Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. | Stat Med | 1999 | https://conductscience.org/library/papers/10204198 | PubMed |
| 20 | 28287639 | Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. | Bone Marrow Transplant | 2017 | https://conductscience.org/library/papers/28287639 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42712389 | Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42712389 | PubMed |
| 42292451 | Editorial: NK cells in transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292451 | PubMed |
| 40934005 | Prediction and effect on relapse of natural killer cell alloreactivity based on KIR-HLA interactions in pediatric haploidentical transplantation with anti-thymoglobulin. | Front Immunol | 2025 | https://conductscience.org/library/papers/40934005 | PubMed |
| 40810334 | Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation. | Br J Haematol | 2025 | https://conductscience.org/library/papers/40810334 | PubMed |
| 40710344 | Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation. | Cells | 2025 | https://conductscience.org/library/papers/40710344 | PubMed |
| 39737173 | Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/39737173 | PubMed |
| 38964919 | [The impact of donor human leukocyte antigen-Bw4 allele on natural killer cell reconstitution and transplant-related mortality in haploidentical transplantation]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | https://conductscience.org/library/papers/38964919 | PubMed |
| 38903503 | Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/38903503 | PubMed |
| 38889342 | Future directions in haploidentical hematopoietic stem cell transplantation. | Hematology | 2024 | https://conductscience.org/library/papers/38889342 | PubMed |
| 38817602 | The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/38817602 | PubMed |
| 37228595 | NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | https://conductscience.org/library/papers/37228595 | PubMed |
| 36311784 | Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy. | Front Immunol | 2022 | https://conductscience.org/library/papers/36311784 | PubMed |
| 35994137 | The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia. | Stem Cell Rev Rep | 2023 | https://conductscience.org/library/papers/35994137 | PubMed |
| 35022535 | The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML. | Bone Marrow Transplant | 2022 | https://conductscience.org/library/papers/35022535 | PubMed |
| 34778077 | Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective. | Front Oncol | 2021 | https://conductscience.org/library/papers/34778077 | PubMed |
| 34595443 | Haploidentical Hematopoietic Stem Cell Transplantation Followed by 'Post-Cyclophosphamide': The Future of Allogeneic Stem Cell Transplant. | Clin Hematol Int | 2020 | https://conductscience.org/library/papers/34595443 | PubMed |
| 34413848 | Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia. | Front Immunol | 2021 | https://conductscience.org/library/papers/34413848 | PubMed |
| 33674791 | Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/33674791 | PubMed |
| 33496734 | Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide. | Blood Adv | 2021 | https://conductscience.org/library/papers/33496734 | PubMed |
| 33193367 | Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation. | Front Immunol | 2020 | https://conductscience.org/library/papers/33193367 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KIR2DL4 | 3805 | PubTator's text mining | https://conductscience.org/library/genes/3805 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29907809
GET https://conductscience.org/api/papers/v1/29907809/references?page=2